Blood Conservation Strategies
On this page
Direct answer
The safest blood for a surgical patient is the patient's own, kept circulating. Patient blood management rests on three pillars: detect and treat anaemia before surgery (oral iron over weeks, intravenous ferric carboxymaltose when time is short, erythropoietin in selected contexts); minimise peri-operative loss (meticulous haemostasis, tranexamic acid, cell salvage, acute normovolaemic haemodilution, controlled hypotension); and tolerate physiological anaemia — transfusing at a haemoglobin of 7 g/dL in stable patients rather than a fixed "10/30" rule, a position built on the TRICC trial (7 versus 10 g/dL in critical illness, no mortality difference) and FOCUS (8 versus 10 after hip surgery, same answer). Each unit avoided dodges infection, reaction and volume overload — and the chronic blood-shortage reality of Indian surgical services.
What you must remember
- Three pillars: optimise haemopoiesis preoperatively (anaemia clinic — iron studies, ferritin), reduce bleeding (drugs and technique), and use restrictive transfusion thresholds (haemodynamic instability, not numbers alone, drives exceptions).
- Restrictive triggers: transfuse stable patients at haemoglobin below 7 g/dL; 8 g/dL remains reasonable after cardiac surgery, in symptomatic orthogeriatric patients and in unstable bleeding; the "transfuse at 10" era ended with TRICC and FOCUS — one unit at a time, reassess after each.
- Tranexamic acid: lysine-analogue antifibrinolytic — 1 g IV (trauma and obstetric evidence from CRASH-2 and WOMAN; 10-15 mg/kg dosing in joint replacement); caution with high doses in renal impairment (seizures) and contraindicated in active thromboembolism.
- Cell salvage: collect, wash and return the patient's own shed red cells in cardiac, vascular and major orthopaedic surgery; relative contraindications historically included malignancy (leucocyte filters have narrowed this), bowel contamination and sickle cell disease.
- Acute normovolaemic haemodilution (ANH): remove 1-3 units after induction, replace with crystalloid or colloid, reinfuse fresh autologous blood at the end — useful where predicted loss is 1-2 litres and the patient's cardiac reserve permits.
- IV iron and EPO: ferric carboxymaltose corrects iron-deficiency anaemia within a couple of weeks when surgery cannot wait for oral iron; erythropoietin with iron is reserved for renal anaemia and patients who refuse transfusion.
- Theatre behaviour: controlled hypotension (MAP 50-65 mmHg) in fit patients, tourniquets, topical haemostatics (fibrin sealants, oxidised cellulose) and rational anticoagulant stopping.
- Viscoelastic testing (TEG/ROTEM) guides component therapy during active bleeding — plasma and platelets only when the trace says so, ending the "two units of FFP per unit of red cells" folklore.
A pathway in practice
A 55-year-old Jehovah's Witness with haemoglobin 7.9 g/dL is listed for revision hip surgery — the stress test of any blood-conservation service. Six weeks out: IV iron and erythropoietin lift the haemoglobin toward 10; aspirin stopped. In theatre: combined spinal-epidural allows controlled hypotension, tranexamic acid runs before incision, cell salvage returns 400 mL of washed red cells, and meticulous haemostasis limits loss to 700 mL. Postoperatively: micro-sampling for bloods, oral iron, and tolerance of a physiological nadir with supplemental oxygen. Every element is equally standard care for the ordinary anaemic patient — the Indian everyday.
Perspective: exam and practice
The theory paper asks for trials and thresholds: TRICC (7 vs 10, ICU), FOCUS (8 vs 10, hip surgery), the tranexamic acid dose and its seizure caution, and the definition of ANH. The viva trap is the stable postoperative patient with a haemoglobin of 8 who "looks pale" — the correct answer is single-unit transfusion only if symptomatic or haemodynamically significant, with the number treated as a trigger for assessment, not an automatic order. Indian examiners accept two local points gladly: chronic blood shortage makes PBM an ethical as much as a medical argument, and treating preoperative anaemia — highly prevalent in Indian surgical populations — is the highest-yield strategy because it costs less than one unit of packed cells.
Frequently asked questions
What are the three pillars of patient blood management?
Detect and treat anaemia preoperatively, minimise intra-operative blood loss with drugs and technique, and apply restrictive transfusion thresholds with physiological tolerance of anaemia.
At what haemoglobin level should a stable postoperative patient be transfused?
At or below 7 g/dL in stable patients (8 g/dL after cardiac surgery or when symptomatic), transfusing one unit at a time with reassessment — per TRICC and FOCUS evidence.
How does tranexamic acid reduce surgical bleeding?
It blocks lysine-binding sites on plasminogen, inhibiting fibrinolysis; a 1 g IV dose reduces bleeding and mortality in trauma (CRASH-2) and postpartum haemorrhage (WOMAN).
What is acute normovolaemic haemodilution?
Blood is withdrawn after induction and simultaneously replaced with crystalloid or colloid, then the fresh autologous units are reinfused at the end — reducing red-cell loss per millilitre of surgical bleeding.
Which patients should not receive cell-salvaged blood?
Traditionally contraindicated or relatively contraindicated in bowel contamination, sickle cell disease and (with modern leucocyte filters, increasingly relative) malignancy with tumour contamination of the field.